Quick Answer
Edwards Lifesciences Corp reported Research And Development Expense of $1.08 billion for the year ending 2025.
- Edwards Lifesciences Corp showed an increase of +2.5% in Research And Development Expense from 2024 to 2025.
- This data is from Edwards Lifesciences Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2010: $45.20 million | Q2 2010: $50.60 million | Q3 2010: $52.70 million | Q1 2011: $59.00 million | Q2 2011: $64.90 million | Q3 2011: $61.70 million | Q1 2012: $68.60 million | Q2 2012: $74.00 million | Q3 2012: $73.80 million | Q1 2013: $79.80 million | Q2 2013: $80.50 million | Q3 2013: $84.10 million | Q1 2014: $85.80 million | Q2 2014: $89.10 million | Q3 2014: $87.60 million | Q1 2015: $86.40 million | Q2 2015: $97.50 million | Q3 2015: $101.00 million | Q1 2016: $101.80 million | Q2 2016: $112.50 million | Q3 2016: $113.00 million | Q1 2017: $128.70 million | Q2 2017: $134.40 million | Q3 2017: $142.90 million | Q1 2018: $143.20 million | Q2 2018: $154.10 million | Q3 2018: $161.80 million | Q1 2019: $171.40 million | Q2 2019: $191.90 million | Q3 2019: $195.50 million | Q1 2020: $187.40 million | Q2 2020: $182.10 million | Q3 2020: $195.50 million | Q1 2021: $207.00 million | Q2 2021: $225.30 million | Q3 2021: $238.00 million | Q1 2022: $228.60 million | Q2 2022: $250.80 million | Q3 2022: $233.60 million | Q1 2023: $261.20 million | Q2 2023: $243.70 million | Q3 2023: $242.80 million | Q1 2024: $256.70 million | Q2 2024: $271.80 million | Q3 2024: $253.40 million | Q1 2025: $254.60 million | Q2 2025: $276.20 million | Q3 2025: $280.70 million.
- Over the full 18 years of available data (2008 to 2025), Edwards Lifesciences Corp's Research And Development Expense has grown by 675.3%.
- Historical annual values: Fiscal year 2025: $1.08 billion | Fiscal year 2024: $1.05 billion | Fiscal year 2023: $962.90 million | Fiscal year 2022: $843.60 million | Fiscal year 2021: $903.10 million | Fiscal year 2020: $760.70 million | Fiscal year 2019: $752.70 million | Fiscal year 2018: $622.20 million | Fiscal year 2017: $552.60 million | Fiscal year 2016: $442.20 million | Fiscal year 2015: $382.90 million | Fiscal year 2014: $346.50 million | Fiscal year 2013: $323.00 million | Fiscal year 2012: $291.30 million | Fiscal year 2011: $246.30 million | Fiscal year 2010: $204.40 million | Fiscal year 2009: $175.50 million | Fiscal year 2008: $139.20 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: